1.Effect of Community-Based Interventions for Registering and Managing Diabetes Patients in Rural Areas of Korea: Focusing on Medication Adherence by Difference in Difference Regression Analysis
Hyo-Rim SON ; So Youn PARK ; Hee-Jung YONG ; Seong-Hyeon CHAE ; Eun Jung KIM ; Eun-Sook WON ; Yuna KIM ; Se-Jin BAE ; Chun-Bae KIM
Health Policy and Management 2023;33(1):3-18
Background:
A chronic disease management program including patient education, recall and remind service, and reduction of out-of-pocket payment was implemented in Korea through a chronic care model. This study aimed to assess the effect of a community-based intervention program for improving medication adherence of patients with diabetes mellitus in rural areas of Korea.
Methods:
We applied a non-equivalent control group design using Korean National Health Insurance Big Data. Hongcheon County has been continuously adopting this program since 2012 as an intervention region. Hoengseong County did not adopt such program. It was used as a control region. Subjects were a cohort of patients with diabetes mellitus aged more than 65 years but less than 85 years among residents for 11 years from 2010 to 2020. After 1:1 matching, there were 368 subjects in the intervention region and 368 in the control region. Indirect indicators were analyzed using the difference-in-difference regression according to Andersen’s medical use model.
Results:
The increasing percent point of diabetic patients who continuously received insurance benefits for more than 240 days from 2010 to 2014 and from 2010 to 2020 were 2.6%p and 2.7%p in the intervention region and 3.0%p and 3.9%p in the control region, respectively. The number of dispensations per prescription of diabetic patient in the intervention region increased by approximately 4.61% by month compared to that in the control region.
Conclusion
The intervention program encouraged older people with diabetes mellitus to receive continuous care for overcoming the rule of halves in the community. More research is needed to determine whether further improvement in the continuity of comprehensive care can prevent the progression of cardiovascular diseases.
2.Serological evidence of Anaplasma spp., Borrelia burgdorferi and Ehrlichia canis in dogs from the Republic of Korea by rapid diagnostic test kits
Evelyn Alejandra MIRANDA ; Sun-Woo HAN ; Ji-Min RIM ; Yoon-Kyoung CHO ; Kyoung-Seong CHOI ; Joon-Seok CHAE
Journal of Veterinary Science 2022;23(2):e20-
Background:
Emergent and re-emergent canine tick-borne infections are attracting increasing attention worldwide. The rise in pet ownership and the close relationship between dogs and their owners are the most concerning factors because dogs may act as competent reservoirs for human tick-transmitted infectious agents.
Objectives:
This study contributes to the epidemiological surveillance of canine ticktransmitted infections with zoonotic risk in the Republic of Korea (ROK) by investigating the seroprevalence of the pathogens, Anaplasma spp., Borrelia burgdorferi, and Ehrlichia canis.
Methods:
Four hundred and thirty whole blood samples from domestic dogs were collected in seven metropolitan cities and nine provinces in the ROK and tested using SensPERT Ab test kits (VetAll Laboratories®) to detect seroreactive animals.
Results:
The seroprevalence rates identified were 9.8% (42/430) for Anaplasma spp., 2.8% (12/430) for B. burgdorferi, and 1.4% (6/430) for E. canis. The risk factors evaluated in this study that could be associated with the development of a humoral immune response, such as sex, age, and history of tick exposure, were similar. There was only one exception for dogs seroreactive to Anaplasma spp., where the risk factor “tick exposure” was statistically significant (p = 0.047).
Conclusions
This serological survey exhibited the widespread presence of Anaplasma spp., B.burgdorferi, and E. canis throughout the ROK. Hence, dogs may play a key role as the sentinel animals of multiple zoonotic infectious agents in the country.
3.Muscle Weakness in a Patient with History of Poliomyelitis: A Differential Diagnosis for Post-polio Syndrome (PPS) and Dermatomyositis.
Sang Hee AN ; Ha Young NA ; Seong Hui KANG ; Soo Youn PARK ; Hyung Min YU ; Chae Ho LEE ; Ji Wan KIM ; Se Woong KWON ; Junghwa LEE ; Hae Rim KIM ; Sang Heon LEE
Journal of Rheumatic Diseases 2014;21(3):147-150
Dermatomyositis (DM) is an idiopathic inflammatory myopathy, characterized by inflammation of the proximal skeletal muscles and typical skin manifestations, which results in symmetric muscle weakness. A 43-year-old man was presented with skin rash and left leg weakness, and he had a history of poliomyelitis. Initially, he was diagnosed as having post-polio syndrome (PPS) due to unilateral muscle weakness and a result of an the electromyography (EMG), which had shown patterns of PPS. After 4 months with conservative therapy for PPS, weakness of bilateral upper arms had developed and skin rashes on his entire body had aggravated and progressed. He was diagnosed as having dermatomyositis, based on elevated muscle enzyme levels, typical skin rashes, and typical EMG findings, which indicated muscle disease. When a patient with previous poliomyelitis has a newly developed muscle weakness or pain, we should consider various possible causes other than PPS.
Adult
;
Arm
;
Dermatomyositis*
;
Diagnosis, Differential*
;
Electromyography
;
Exanthema
;
Humans
;
Inflammation
;
Leg
;
Muscle Weakness*
;
Muscle, Skeletal
;
Myositis
;
Poliomyelitis*
;
Postpoliomyelitis Syndrome*
;
Skin Manifestations
4.Contributors of the Severity of Airflow Limitation in COPD Patients.
Yoonki HONG ; Eun Jin CHAE ; Joon Beom SEO ; Ji Hyun LEE ; Eun Kyung KIM ; Young Kyung LEE ; Tae Hyung KIM ; Woo Jin KIM ; Jin Hwa LEE ; Sang Min LEE ; Sangyeub LEE ; Seong Yong LIM ; Tae Rim SHIN ; Ho Il YOON ; Seung Soo SHEEN ; Seung Won RA ; Jae Seung LEE ; Jin Won HUH ; Sang Do LEE ; Yeon Mok OH
Tuberculosis and Respiratory Diseases 2012;72(1):8-14
BACKGROUND: Although airway obstruction in chronic obstructive pulmonary disease (COPD) is due to pathologic processes in both the airways and the lung parenchyma, the contribution of these processes, as well as other factors, have not yet been evaluated quantitatively. We therefore quantitatively evaluated the factors contributing to airflow limitation in patients with COPD. METHODS: The 213 COPD patients were aged >45 years, had smoked >10 pack-years of cigarettes, and had a post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) <0.7. All patients were evaluated by medical interviews, physical examination, spirometry, bronchodilator reversibility tests, lung volume, and 6-minute walk tests. In addition, volumetric computed tomography (CT) was performed to evaluate airway wall thickness, emphysema severity, and mean lung density ratio at full expiration and inspiration. Multiple linear regression analysis was performed to identify the variables independently associated with FEV1 - the index of the severity of airflow limitation. RESULTS: Multiple linear regression analysis showed that CT measurements of mean lung density ratio (standardized coefficient beta=-0.46; p<0.001), emphysema severity (volume fraction of the lung less than -950 HU at full inspiration; beta=-0.24; p<0.001), and airway wall thickness (mean wall area %; beta=-0.19, p=0.001), as well as current smoking status (beta=-0.14; p=0.009) were independent contributors to FEV1. CONCLUSION: Mean lung density ratio, emphysema severity, and airway wall thickness evaluated by volumetric CT and smoking status could independently contribute to the severity of airflow limitation in patients with COPD.
Aged
;
Airway Obstruction
;
Cone-Beam Computed Tomography
;
Emphysema
;
Forced Expiratory Volume
;
Humans
;
Linear Models
;
Lung
;
Pathologic Processes
;
Physical Examination
;
Pulmonary Disease, Chronic Obstructive
;
Smoke
;
Smoking
;
Spirometry
;
Tobacco Products
;
Tomography, X-Ray Computed
;
Vital Capacity
5.Predictors of Pulmonary Function Response to Treatment with Salmeterol/fluticasone in Patients with Chronic Obstructive Pulmonary Disease.
Jae Seung LEE ; Jin Won HUH ; Eun Jin CHAE ; Joon Beom SEO ; Seung Won RA ; Ji Hyun LEE ; Eun Kyung KIM ; Young Kyung LEE ; Tae Hyung KIM ; Woo Jin KIM ; Jin Hwa LEE ; Sang Min LEE ; Sangyeub LEE ; Seong Yong LIM ; Tae Rim SHIN ; Ho Il YOON ; Seung Soo SHEEN ; Yeon Mok OH ; Sang Do LEE
Journal of Korean Medical Science 2011;26(3):379-385
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and responses to therapies are highly variable. The aim of this study was to identify the predictors of pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD. A total of 127 patients with stable COPD from the Korean Obstructive Lung Disease (KOLD) Cohort, which were prospectively recruited from June 2005 to September 2009, were analyzed retrospectively. The prediction models for the FEV1, FVC and IC/TLC changes after 3 months of treatment with salmeterol/fluticasone were constructed by using multiple, stepwise, linear regression analysis. The prediction model for the FEV1 change after 3 months of treatment included wheezing history, pre-bronchodilator FEV1, post-bronchodilator FEV1 change and emphysema extent on CT (R = 0.578). The prediction models for the FVC change after 3 months of treatment included pre-bronchodilator FVC, post-bronchodilator FVC change (R = 0.533), and those of IC/ TLC change after 3 months of treatment did pre-bronchodilator IC/TLC and post-bronchodilator FEV1 change (R = 0.401). Wheezing history, pre-bronchodilator pulmonary function, bronchodilator responsiveness, and emphysema extent may be used for predicting the pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD.
Aged
;
Albuterol/*analogs & derivatives/therapeutic use
;
Androstadienes/*therapeutic use
;
Bronchodilator Agents/*therapeutic use
;
Emphysema
;
Female
;
Humans
;
Linear Models
;
Lung/physiopathology
;
Male
;
Middle Aged
;
Prognosis
;
Pulmonary Disease, Chronic Obstructive/*drug therapy
;
Republic of Korea
;
Respiratory Function Tests
;
Retrospective Studies
;
Tomography Scanners, X-Ray Computed
;
Treatment Outcome
6.Comparison of Clinico-Physiologic and CT Imaging Risk Factors for COPD Exacerbation.
Jung Wan YOO ; Yoonki HONG ; Joon Beom SEO ; Eun Jin CHAE ; Seung Won RA ; Ji Hyun LEE ; Eun Kyung KIM ; Seunghee BAEK ; Tae Hyung KIM ; Woo Jin KIM ; Jin Hwa LEE ; Sang Min LEE ; Sangyeub LEE ; Seong Yong LIM ; Tae Rim SHIN ; Ho Il YOON ; Seung Soo SHEEN ; Jae Seung LEE ; Jin Won HUH ; Yeon Mok OH ; Sang Do LEE
Journal of Korean Medical Science 2011;26(12):1606-1612
To date, clinico-physiologic indices have not been compared with quantitative CT imaging indices in determining the risk of chronic obstructive pulmonary disease (COPD) exacerbation. We therefore compared clinico-physiologic and CT imaging indices as risk factors for COPD exacerbation in patients with COPD. We retrospectively analyzed 260 COPD patients from pulmonary clinics at 11 hospitals in Korea from June 2005 to November 2009 and followed-up for at least one year. At the time of enrollment, none of these patients had COPD exacerbations for at least 2 months. All underwent clinico-physiologic and radiological evaluation for risk factors of COPD exacerbation. After 1 yr, 106 of the 260 patients had at least one exacerbation of COPD. Multiple logistic regression analysis showed that old age, high Charlson Index, and low FEV1 were significant in a clinico-physiologic model, with C-statistics of 0.69, and that increased age and emphysema index were significant in a radiologic model, with C-statistics of 0.64. The difference between the two models was statistically significant (P = 0.04 by bootstrap analysis). Combinations of clinico-physiologic risk factors may be better than those of imaging risk factors in predicting COPD exacerbation.
Aged
;
Aged, 80 and over
;
Disease Progression
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pulmonary Disease, Chronic Obstructive/*diagnosis/pathology/*physiopathology
;
Retrospective Studies
;
Risk Factors
;
Severity of Illness Index
;
*Tomography, X-Ray Computed
7.Over-expression of Liver X Receptor-alpha(LXR alpha by TO901317 Exaggerated the Production of Mesangial Matrix.
Ho Jun CHIN ; Yan Yan FU ; Young Rim SONG ; En Sung LEE ; Yun Mi LEE ; Seong Gyun KIM ; Ki Young NA ; Suhnggwon KIM ; Dong Wan CHAE
Korean Journal of Nephrology 2010;29(2):189-197
PURPOSE: To provide the insight into the role of LXR alpha on the progression of diabetic nephropathy, we measured the production of extracellular matrix in the cultured mesangial cells treated with the LXR agonist. METHODS: With the mesangial cells extracted from C57BL6 mice, we cultured them in the presence of 25 mM glucose with or without TO901317, an agonist of LXRalpha We transfected siRNAs of SREBP1 and LXR alpha into the mesangial cell to suppress the activity of the two genes. RESULTS: TO901317 increased expressions of LXR alpha, SREBP-1, TGF beta-1, and collagen IV and triglyceride amount in mesangial cells cultured in 25mM glucose. These effects of TO901317 were attenuated by inhibiting transcription of LXR alpha or SREBP-1 with transfection of siRNAs. In mesangial cells transfected with siRNA of SREBP-1, changes by TO901317 were attenuated regardless of increased expression of LXR alpha. That suggested the activation of SREBP-1, an downstream gene of LXR alpha, would be more important to induce changes in mesangial cells by TO901317. CONCLUSION: The TO901317, an agonist of LXR alpha, increases extracellular matrix, collagen IV, and TGF beta-1 production in cultured mesangial cells. The SREBP-1 as well as dyslipidemia in mesangial cells enhanced by LXR agonist would be the important mechanism to induce those changes.
Animals
;
Collagen
;
Diabetic Nephropathies
;
Dyslipidemias
;
Extracellular Matrix
;
Glucose
;
Hypertriglyceridemia
;
Liver
;
Mesangial Cells
;
Mice
;
Orphan Nuclear Receptors
;
RNA, Small Interfering
;
Sterol Regulatory Element Binding Protein 1
;
Transfection
8.The Mildly Elevated Serum Bilirubin Level is Negatively Associated with the Incidence of End Stage Renal Disease in Patients with IgA Nephropathy.
Ho Jun CHIN ; Hyun Jin CHO ; Tae Woo LEE ; Ki Young NA ; Kook Hwan OH ; Kwon Wook JOO ; Hyung Jin YOON ; Yon Su KIM ; Curie AHN ; Jin Suk HAN ; Suhnggwon KIM ; En Sil JEON ; Dong Chan JIN ; Yong Lim KIM ; Sun Hee PARK ; Chan Duck KIM ; Young Rim SONG ; Seong Gyun KIM ; Yoon Goo KIM ; Jung Eun LEE ; Yoon Kyu OH ; Chun Soo LIM ; Sang Koo LEE ; Dong Wan CHAE ; Won Yong CHO ; Hyoung Kyu KIM ; Sang Kyung JO
Journal of Korean Medical Science 2009;24(Suppl 1):S22-S29
Oxidative stress plays various roles in the development and progression of IgA nephropathy, while bilirubin is known as a potent antioxidant. We therefore hypothesized that serum bilirubin would be associated with renal prognosis in IgA nephropathy. The study subjects comprised 1,458 adult patients with primary IgA nephropathy in Korea. We grouped patients according to the following quartile levels of bilirubin: <0.4 mg/dL (Q1), 0.4-0.5 mg/dL (Q2), 0.6-0.7 mg/dL (Q3), and >0.8 mg/dL (Q4). The outcome data were obtained from the Korean Registry of end-stage renal disease (ESRD). Eighty patients (5.5%) contracted ESRD during a mean follow-up period of 44.9 months. The ESRD incidences were 10.7% in Q1, 8.2% in Q2, 2.8% in Q3, and 2.8% in Q4 (p<0.001). The relative risk of ESRD compared to that in Q1 was 0.307 (95% confidence interval [CI], 0.126-0.751) in Q3 and 0.315 (95% CI, 0.130-0.765) in Q4. The differences of ESRD incidence were greater in subgroups of males and of patients aged 35 yr or more, with serum albumin 4.0 g/dL or more, with normotension, with eGFR 60 mL/min/1.73 m2 or more, and with proteinuria less then 3+ by dipstick test. In conclusion, higher bilirubin level was negatively associated with ESRD incidence in IgA nephropathy.
Adult
;
Bilirubin/*blood
;
Disease Progression
;
Female
;
Glomerular Filtration Rate
;
Glomerulonephritis, IGA/*blood/complications
;
Humans
;
Hypertension/complications
;
Incidence
;
Kidney Failure, Chronic/*blood/complications
;
Male
;
Middle Aged
;
Risk
;
Risk Factors
;
Treatment Outcome
9.Use of Magnesium in Anesthesiology and Pain Medicine.
Yeungnam University Journal of Medicine 2009;26(2):93-101
The use of magnesium sulphate has recently increased in anesthesiology and pain medicine. The roles of magnesium sulphate are as an analgesic adjuvant, a vasodilator, a calcium channel blocker and reducing the anesthetic requirement. These effect are primarily based on the regulation of calcium influx into the cell and antagonism of the N-methyl-D-aspartate receptor. We discuss here the clinical effects of magnesium sulphate on anesthesiology and pain medicine.
Anesthesiology
;
Calcium
;
Calcium Channels
;
Magnesium
;
N-Methylaspartate
10.Intravenous Vitamin K-induced Cardiovascular Collapse : A case report.
Sang Jin PARK ; Chae Rim SEONG ; Dae Lim JEE
Korean Journal of Anesthesiology 2007;52(4):461-464
A cardiovascular collapse, due to preoperatively administered intravenous vitamin K (phytonadione), was experienced in a 59-year-old woman who was scheduled to undergo a left upper lung lobectomy. The patient developed sudden facial flushing, an upper torso rash, dyspnea, palpitation, and severe hypotension about 2 min after the intravenous administration of approximately 2 mg of vitamin K. Immediate hydration and an injection of 20 mg ephedrine restored her blood pressure to the preoperative level within 5 min. The patient recovered without any sequelae, but the operation was postponed. The patient's symptoms seemed to be due to an anaphylactoid reaction or anaphylaxis following the intravenous administration of vitamin K. This case report suggests that physicians should carefully review the indications of vitamin K prior to administration, even at low doses.
Administration, Intravenous
;
Anaphylaxis
;
Blood Pressure
;
Dyspnea
;
Ephedrine
;
Exanthema
;
Female
;
Flushing
;
Humans
;
Hypotension
;
Lung
;
Middle Aged
;
Torso
;
Vitamin K
;
Vitamins*

Result Analysis
Print
Save
E-mail